| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1029055277 |
| P356 | DOI | 10.1038/SJ.NPP.1301233 |
| P698 | PubMed publication ID | 17063154 |
| P5875 | ResearchGate publication ID | 6733249 |
| P50 | author | David A. Lewis | Q28112847 |
| Karl-Anton Dorph-Petersen | Q54086636 | ||
| P2093 | author name string | Allan R Sampson | |
| Qiang Wu | |||
| Glenn T Konopaske | |||
| Joseph N Pierri | |||
| P2860 | cites work | A review of MRI findings in schizophrenia | Q24657354 |
| Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator | Q29619043 | ||
| The neuropathology of schizophrenia. A critical review of the data and their interpretation | Q30573678 | ||
| Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine Trial | Q31995598 | ||
| The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys | Q33985626 | ||
| Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. | Q34357875 | ||
| Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study | Q34392600 | ||
| Antipsychotic drug effects on brain morphology in first-episode psychosis | Q34408860 | ||
| Turnover of resident microglia in the normal adult mouse brain | Q34435397 | ||
| Cell death and control of cell survival in the oligodendrocyte lineage | Q34460930 | ||
| Tissue shrinkage and unbiased stereological estimation of particle number and size | Q34570827 | ||
| Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice | Q36109567 | ||
| Glial cell lineage in the cerebral cortex: A review and synthesis | Q37085600 | ||
| Longitudinal study of brain morphology in first episode schizophrenia | Q40718665 | ||
| Olanzapine produces trophic effects in vitro and stimulates phosphorylation of Akt/PKB, ERK1/2, and the mitogen-activated protein kinase p38. | Q42829026 | ||
| Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia | Q43807495 | ||
| Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide | Q44516603 | ||
| Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus | Q44882892 | ||
| Neurotoxic potential of haloperidol in comparison with risperidone: implication of Akt-mediated signal changes by haloperidol | Q44914407 | ||
| The efficiency of systematic sampling in stereology and its prediction. | Q44974729 | ||
| Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. | Q45307345 | ||
| Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs. | Q46549241 | ||
| A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis | Q46735618 | ||
| Long-term exposure to the atypical antipsychotic olanzapine differently up-regulates extracellular signal-regulated kinases 1 and 2 phosphorylation in subcellular compartments of rat prefrontal cortex. | Q46878024 | ||
| Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density | Q47450317 | ||
| Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia | Q47820010 | ||
| 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. | Q47863120 | ||
| Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. | Q48092214 | ||
| Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia | Q48135249 | ||
| Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure | Q48153941 | ||
| Synaptic rearrangements in medial prefrontal cortex of haloperidol-treated rats | Q48435138 | ||
| Smaller frontal gray matter volume in postmortem schizophrenic brains | Q48438836 | ||
| A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures | Q48519543 | ||
| A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. | Q48752276 | ||
| Mapping auditory core, lateral belt, and parabelt cortices in the human superior temporal gyrus | Q48794482 | ||
| Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. | Q51941101 | ||
| Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: volume, neuron number, and cell types. | Q52000103 | ||
| The efficiency of systematic sampling in stereology--reconsidered. | Q52213559 | ||
| Optimizing sampling efficiency of stereological studies in biology: or 'do more less well!'. | Q52747899 | ||
| The relationship between D 2 receptor occupancy and plasma levels on low dose oral haloperidol: a PET study | Q59739881 | ||
| Radioautographic evidence for slow astrocyte turnover and modest oligodendrocyte production in the corpus callosum of adult mice infused with 3H-thymidine | Q68415326 | ||
| Gliogenesis of astrocytes and oligodendrocytes in the neocortical grey and white matter of the adult rat: electron microscopic analysis of light radioautographs | Q71402173 | ||
| Evidence for large-scale astrocyte death in the developing cerebellum | Q72240778 | ||
| Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors | Q72734923 | ||
| No deficit in total number of neurons in the prefrontal cortex in schizophrenics | Q73711369 | ||
| Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus | Q74453176 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Macaca | Q177601 |
| P304 | page(s) | 1216-1223 | |
| P577 | publication date | 2006-10-25 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys | |
| P478 | volume | 32 |
| Q26749677 | A Review of Impaired Neuroplasticity in Schizophrenia Investigated with Non-invasive Brain Stimulation |
| Q48681125 | A longitudinal study of cortical changes and their cognitive correlates in patients followed up after first-episode psychosis |
| Q36692829 | A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia. |
| Q34589580 | Anatomical abnormalities in gray and white matter of the cortical surface in persons with schizophrenia |
| Q50759017 | Antipsychotic drugs for prevention of relapse. |
| Q57825253 | Are structural brain changes in schizophrenia related to antipsychotic medication? A narrative review of the evidence from a clinical perspective |
| Q34706991 | Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia |
| Q47583502 | Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains. |
| Q35852767 | Autophagy inhibition uncovers the neurotoxic action of the antipsychotic drug olanzapine. |
| Q33948574 | Brain tissue changes and antipsychotic medication |
| Q48653346 | Brain volume changes in schizophrenia: how do they arise? What do they mean? |
| Q94600188 | Characteristics of gray matter alterations in never-treated and treated chronic schizophrenia patients |
| Q52356865 | Clinical Findings Documenting Cellular and Molecular Abnormalities of Glia in Depressive Disorders. |
| Q34339682 | Decrease in temporal gyrus gray matter volume in first-episode, early onset schizophrenia: an MRI study |
| Q51892906 | Editorial: a global perspective on child and adolescent mental health. |
| Q24654374 | Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys |
| Q89891607 | Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial |
| Q36270869 | Expression of angiotensinogen and receptors for angiotensin and prorenin in the rat and monkey striatal neurons and glial cells. |
| Q37224949 | Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology |
| Q27008060 | How should we intervene in psychosis risk syndromes? |
| Q57727112 | Increased neuronal cell number in the dorsal motor nucleus of the vagus in schizophrenia |
| Q48186224 | Lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder |
| Q33814201 | Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. |
| Q34681347 | Long-term antipsychotic use and brain changes in schizophrenia - a systematic review and meta-analysis |
| Q47785708 | Loss of precuneus dendritic spines immunopositive for spinophilin is related to cognitive impairment in early Alzheimer's disease. |
| Q39232878 | Microvascular anomaly conditions in psychiatric disease. Schizophrenia - angiogenesis connection |
| Q33950987 | Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness |
| Q101403037 | N-acetylcysteine prevents olanzapine-induced oxidative stress in mHypoA-59 hypothalamic neurons |
| Q34509385 | NeuN+ neuronal nuclei in non-human primate prefrontal cortex and subcortical white matter after clozapine exposure |
| Q34552937 | Neuroimaging findings in the at-risk mental state: a review of recent literature |
| Q47399217 | Neuronal density and proportion of interneurons in the associative, sensorimotor and limbic human striatum |
| Q34111775 | Neuroprogressive effects of lifetime illness duration in older adults with bipolar disorder |
| Q39646600 | Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness |
| Q34274859 | Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents |
| Q35960362 | Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment |
| Q36395044 | Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia |
| Q36250442 | Psychotic symptoms and gray matter deficits in clinical pediatric populations |
| Q37417633 | Pyramidal neuron number in layer 3 of primary auditory cortex of subjects with schizophrenia. |
| Q37727085 | Regional differences in the action of antipsychotic drugs: implications for cognitive effects in schizophrenic patients |
| Q34337272 | Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. |
| Q34176902 | Selection of reference gene expression in a schizophrenia brain cohort |
| Q34279949 | Stereological Approaches to Identifying Neuropathology in Psychosis |
| Q31066630 | Stereological analysis of neuron, glial and endothelial cell numbers in the human amygdaloid complex |
| Q35126233 | Stereological analysis of the rat and monkey amygdala |
| Q91959868 | Synaptic functions and their disruption in schizophrenia: From clinical evidence to synaptic optogenetics in an animal model |
| Q55383447 | Thalamocortical Projection Neuron and Interneuron Numbers in the Visual Thalamic Nuclei of the Adult C57BL/6 Mouse. |
| Q24643935 | The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia |
| Q33951370 | The course of brain abnormalities in schizophrenia: can we slow the progression? |
| Q22242827 | The dopamine hypothesis of schizophrenia: version III--the final common pathway |
| Q96773916 | The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia |
| Q37813206 | The treatment of cognitive impairment in schizophrenia |
| Q33703935 | Volume and neuron number of the lateral geniculate nucleus in schizophrenia and mood disorders |
| Q48148097 | White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment |
| Q87945859 | [Frontal brain volume reduction due to antipsychotic drugs?] |
| Q45958384 | [Personalised medicine in psychiatry and psychotherapy. A review of the current state-of-the-art in the biomarker-based early recognition of psychoses]. |
Search more.